Blog
Tree.com (TREE) Is Attractively Priced Despite Fast-paced Momentum
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks
Sally Beauty (SBH) Is Attractively Priced Despite Fast-paced Momentum
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
How to Boost Your Portfolio with Top Retail and Wholesale Stocks Set to Beat Earnings
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
What Makes Idaho Strategic Resources (IDR) a Good Fit for 'Trend Investing'
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a
Recent Price Trend in Century (CENX) is Your Friend, Here's Why
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure
Here Is Why Bargain Hunters Would Love Fast-paced Mover Gentherm (THRM)
Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Onto Innovation's Q2 Earnings Miss Estimates, Top Line Up 5% Y/Y
Onto Innovation Inc. ONTO reported second-quarter 2025 earnings per share of $1.25, which missed the Zacks Consensus Estimate by 1.6%. The bottom line compared unfavorably with the prior-year
TEM's Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
Tempus AI, Inc. TEM reported a second-quarter 2025 adjusted loss of 22 cents per share, narrower than the Zacks Consensus Estimate by 4.35%.
GAAP loss per share was 25 cents compared with a loss of
PAR Technology (PAR) Q2 Earnings Lag Estimates
PAR Technology (PAR) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to a loss of $0.23 per share a year ago. These
fuboTV Inc. (FUBO) Q2 Earnings and Revenues Beat Estimates
fuboTV Inc. (FUBO) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.04 per share a year ago. These figures
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
Hologic’s HOLX Diagnostics unit, the largest by revenues, has been the most impacted by geopolitical headwinds this year. Cuts in USAID funding have affected its HIV testing business in Africa
Alpha Metallurgical (AMR) Reports Q2 Loss, Misses Revenue Estimates
Alpha Metallurgical (AMR) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $2.38. This compares to earnings of $4.49 per share a year ago. These
Soho House & Co (SHCO) Beats Q2 Earnings and Revenue Estimates
Soho House & Co (SHCO) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to a loss of $0.17 per share a year ago
If You Invested $1000 in Arista Networks a Decade Ago, This is How Much It'd Be Worth Now
How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across
Here's How Much a $1000 Investment in Celestica Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
Here's How Much a $1000 Investment in Williams-Sonoma Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates
SurModics (SRDX) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.21 per share. This compares to a loss of $0.27 per share a year ago. These
CPI Card Group Inc. (PMTS) Lags Q2 Earnings and Revenue Estimates
CPI Card Group Inc. (PMTS) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.51 per share a year ago
Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates
Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.37 per share a year ago. These
AMC Networks (AMCX) Tops Q2 Earnings and Revenue Estimates
AMC Networks (AMCX) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $1.24 per share a year ago. These
Wendy's (WEN) Tops Q2 Earnings and Revenue Estimates
Wendy's (WEN) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.27 per share a year ago. These figures are
TeraWulf Inc. (WULF) Reports Q2 Loss, Tops Revenue Estimates
TeraWulf Inc. (WULF) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.03 per share a year ago. These figures
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates
Repare Therapeutics Inc. (RPTX) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.82 per share a year ago. These
Under Armour (UAA) Misses Q1 Earnings Estimates
Under Armour (UAA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.01 per share a year ago. These


